NKTR
Nektar Therapeutics
Price:  
51.07 
USD
Volume:  
1,351,200.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

NKTR Fair Value

-405.02 %
Upside

What is the fair value of NKTR?

As of 2025-09-18, the Fair Value of Nektar Therapeutics (NKTR) is -155.77 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 51.07 USD, the upside of Nektar Therapeutics is -405.02%.

Is NKTR a good investment?

With the market price of 51.07 USD and our fair value calculation, Nektar Therapeutics (NKTR) is not a good investment. Investing in NKTR stocks now will result in a potential loss of 405.02%.

Note: valuation result may not be accurate due to the company's negative EPS.

51.07 USD
Stock Price
-155.77 USD
Fair Price
FAIR VALUE CALCULATION

NKTR Fair Value

Peter Lynch's formula is:

NKTR Fair Value
= Earnings Growth Rate x TTM EPS
NKTR Fair Value
= 18.59 x -8.38
NKTR Fair Value
= -155.77

The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.

Historical Earnings
2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31 5Y Avg
Net income -444.40 -523.80 -368.20 -276.06 -118.96 -346.28
YoY growth -0.84% -17.87% 29.71% 25.03% 56.91% 18.59%

NKTR Fair Value - Key Data

Market Cap (mil) 717.89
P/E
Forward P/E
EPS -8.38
Avg earnings growth rate 18.59%
TTM earnings -117.81